PD-1 inhibitor immunotherapy for B cell lymphoma

Share This Post

A review written by Young, MD, Anderson Cancer Center, USA explained the application of PD-1 inhibitor immunotherapy in B-cell lymphoma. (Blood. Online version on November 8, 2017. doi: 10.1182 / blood-2017-07-740993.)

PD-1 immune checkpoint inhibitor treatment has shown significant efficacy in the treatment of advanced tumors including hematological malignancies. This review focuses on the clinical trials of PD-1 / PD-L1 expression and PD-1 inhibitor immunotherapy for B-cell lymphoma. Relapsed and refractory classic Hodgkin lymphoma usually have PD-1 positive tumor infiltrating T cells, 9p24 gene changes and high PD-L expression. In Phase I / II clinical trials, PD-1 inhibitors alone can bring an objective response rate (ORR) of 65% to 87% and continuous disease control. The median duration of remission in a phase II clinical trial was 16 months. In a phase I clinical trial, nivolumab was used to treat relapsed and refractory B-cell non-Hodgkin’s lymphoma including follicular lymphoma (CD4 positive T cells in the tumor usually have a large amount of PD-1 expression) and diffuse large B cell lymphoma Tumors (also express PD-1 and PD-L1 to varying degrees). Primary mediastinal large B-cell lymphoma often has 9p24 changes. In a phase II clinical trial, the ORR of pembrolizumab was 35%, the ORR of pembrolizumab was 0, and the treatment was Richter transformation. The ORR of chronic lymphocytic leukemia is 44%. Marginal zone lymphoma also has PD-1 expression, but mantle cell lymphoma does not. The review also describes the mechanism of PD-1 inhibitor immunotherapy, toxic reactions, predictive markers and combination treatment strategies.

Subscribe To Our Newsletter

Get updates and never miss a blog from Cancerfax

More To Explore

Need help? Our team is ready to assist you.

We wish a speedy recovery of your dear and near one.

درمان سرطان در تركيه
Start chat
Need help with cancer treatment?
Scan the code
Hello,
Welcome to CancerFax !

CancerFax is the most trusted international patient facilitator working with top cancer hospital's in the world like MD Anderson, Dana Farber, Asan, NCC Japan, Sheba, Beijing Cancer Institute and Apollo to bring you best of therapies and drugs.

Let us know what services would you like to avail?

1) Cancer treatment in the USA, Japan, Israel, India, Korea or Singapore?
2) CAR T-Cell therapy treatment
3) Cancer vaccine
4) Online video consultation
5) Proton therapy